These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21427395)

  • 41. Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.
    Keenan JD; Arzika AM; Maliki R; Boubacar N; Elh Adamou S; Moussa Ali M; Cook C; Lebas E; Lin Y; Ray KJ; O'Brien KS; Doan T; Oldenburg CE; Callahan EK; Emerson PM; Porco TC; Lietman TM
    N Engl J Med; 2019 Jun; 380(23):2207-2214. PubMed ID: 31167050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial.
    Arzika AM; Maliki R; Ali MM; Alio MK; Abdou A; Cotter SY; Varnado NE; Lebas E; Cook C; Oldenburg CE; O'Brien KS; Callahan EK; Bailey RL; West SK; Porco TC; Lietman TM; Keenan JD;
    JAMA Netw Open; 2021 Dec; 4(12):e2139351. PubMed ID: 34967883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM; Oldenburg CE
    Br J Ophthalmol; 2018 May; 102(5):680-686. PubMed ID: 28893761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.
    Keenan JD; Bailey RL; West SK; Arzika AM; Hart J; Weaver J; Kalua K; Mrango Z; Ray KJ; Cook C; Lebas E; O'Brien KS; Emerson PM; Porco TC; Lietman TM;
    N Engl J Med; 2018 Apr; 378(17):1583-1592. PubMed ID: 29694816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety of azithromycin in infants under six months of age in Niger: A community randomized trial.
    Oldenburg CE; Arzika AM; Maliki R; Kane MS; Lebas E; Ray KJ; Cook C; Cotter SY; Zhou Z; West SK; Bailey R; Porco TC; Keenan JD; Lietman TM;
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006950. PubMed ID: 30419040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.
    Campbell JP; Mkocha H; Munoz B; West SK
    Ophthalmic Epidemiol; 2012 Feb; 19(1):38-42. PubMed ID: 22273357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. When the Neighboring Village is Not Treated: Role of Geographic Proximity to Communities Not Receiving Mass Antibiotics for Trachoma.
    Mosenia A; Haile BA; Shiferaw A; Gebresillasie S; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Callahan EK; Zhou Z; Lietman TM; Keenan JD
    Clin Infect Dis; 2023 Mar; 76(6):1038-1042. PubMed ID: 36477547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Azithromycin on the Ocular Surface Microbiome of Children in a High Prevalence Trachoma Area.
    Doan T; Gebre T; Ayele B; Zerihun M; Hinterwirth A; Zhong L; Chen C; Ruder K; Zhou Z; Emerson PM; Porco TC; Keenan JD; Lietman TM
    Cornea; 2022 Oct; 41(10):1260-1264. PubMed ID: 34483276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preventing Long-Term Ocular Complications of Trachoma With Topical Azithromycin: A 3-Year Follow-up Study.
    Afghani T; Mansoor H; Nadeem M
    Asia Pac J Ophthalmol (Phila); 2017; 6(1):8-12. PubMed ID: 28161923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma.
    Keenan JD; Sahlu I; McGee L; Cevallos V; Vidal JE; Chochua S; Hawkins P; Gebre T; Tadesse Z; Emerson PM; Gaynor BD; Lietman TM; Klugman KP
    J Pediatric Infect Dis Soc; 2016 Jun; 5(2):222-6. PubMed ID: 27199475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cohort and age effects of mass drug administration on prevalence of trachoma: a longitudinal study in rural Tanzania.
    Shekhawat N; Mkocha H; Munoz B; Gaydos C; Dize L; Quinn TC; West SK
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2307-14. PubMed ID: 24448262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania.
    Schachterle SE; Mtove G; Levens JP; Clemens E; Shi L; Raj A; Dumler JS; Munoz B; West S; Sullivan DJ
    Emerg Infect Dis; 2014 Jun; 20(6):941-9. PubMed ID: 24865642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
    J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted Antibiotics for Trachoma: A Cluster-Randomized Trial.
    Melo JS; Aragie S; Chernet A; Tadesse Z; Dagnew A; Hailu D; Haile M; Zeru T; Wittberg DM; Nash SD; Callahan EK; Arnold BF; Porco TC; Lietman TM; Keenan JD
    Clin Infect Dis; 2021 Sep; 73(6):979-986. PubMed ID: 33674869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
    Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
    West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
    J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A targeted, single-dose azithromycin strategy for trachoma.
    Laming AC; Currie BJ; DiFrancesco M; Taylor HR; Mathews JD
    Med J Aust; 2000 Feb; 172(4):163-6. PubMed ID: 10772587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial.
    Haile M; Tadesse Z; Gebreselassie S; Ayele B; Gebre T; Yu SN; Stoller NE; Gaynor BD; Porco TC; Emerson PM; Lietman TM; Keenan JD
    Am J Trop Med Hyg; 2013 Oct; 89(4):717-20. PubMed ID: 24002488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
    Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK
    Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial.
    Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.